Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-25-075707
Filing Date
2025-08-08
Accepted
2025-08-08 16:20:09
Documents
15
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2523009d1_8ka.htm   iXBRL 8-K/A 31885
2 EXHIBIT 99.1 tm2523009d1_ex99-1.htm EX-99.1 124917
7 GRAPHIC tm2523009d1_ex99-img001.jpg GRAPHIC 5171
  Complete submission text file 0001104659-25-075707.txt   392872

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vacc-20250807.xsd EX-101.SCH 3528
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vacc-20250807_def.xml EX-101.DEF 26915
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vacc-20250807_lab.xml EX-101.LAB 36557
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vacc-20250807_pre.xml EX-101.PRE 25539
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2523009d1_8ka_htm.xml XML 5612
Mailing Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874
Business Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40367 | Film No.: 251198720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)